Expression of Sestrin Genes in Radiotherapy for Prostate Cancer and Its Association With Fatigue: A Proof-of-Concept Study
暂无分享,去创建一个
[1] E. Ropelle,et al. Physical exercise increases Sestrin 2 protein levels and induces autophagy in the skeletal muscle of old mice , 2017, Experimental Gerontology.
[2] Suzanne M. Miller,et al. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis , 2017, JAMA oncology.
[3] P. Reddy,et al. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[4] G. Milne,et al. Oxidative stress in relation to diet and physical activity among premenopausal women , 2016, British Journal of Nutrition.
[5] J. Xie,et al. Investigations on the antifatigue and antihypoxic effects of Paecilomyces hepiali extract. , 2016, Molecular medicine reports.
[6] L. Sechrest,et al. Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy. , 2015, Clinical journal of oncology nursing.
[7] L. Teng,et al. Studies on the Antifatigue Activities of Cordyceps militaris Fruit Body Extract in Mouse Model , 2015, Evidence-based complementary and alternative medicine : eCAM.
[8] Jian Huang,et al. AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. , 2015, Metabolism: clinical and experimental.
[9] C. Cleeland,et al. The symptom burden of treatment‐naive patients with head and neck cancer , 2015, Cancer.
[10] R. Elswick,et al. Association of mitochondrial dysfunction and fatigue: A review of the literature , 2014, BBA clinical.
[11] Kallenborn-GerhardtWiebke,et al. Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury. , 2013 .
[12] M. Karin,et al. Sestrins orchestrate cellular metabolism to attenuate aging. , 2013, Cell metabolism.
[13] J. Zierath,et al. Sestrin 3 regulation in type 2 diabetic patients and its influence on metabolism and differentiation in skeletal muscle. , 2013, American journal of physiology. Endocrinology and metabolism.
[14] Claudia X. Aguado Loi,et al. Risk factors associated with increased depressive symptoms among Latinas diagnosed with breast cancer within 5 years of survivorship , 2013, Psycho-oncology.
[15] F. Sanchis-Gomar. Sestrins: Novel antioxidant and AMPK‐modulating functions regulated by exercise? , 2013, Journal of cellular physiology.
[16] L. Saligan,et al. Mitochondria-Related Gene Expression Changes Are Associated With Fatigue in Patients With Nonmetastatic Prostate Cancer Receiving External Beam Radiation Therapy , 2013, Cancer nursing.
[17] J. Armes,et al. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature , 2013, Supportive Care in Cancer.
[18] P. J. Munson,et al. Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways , 2013, Brain, Behavior, and Immunity.
[19] L. Saligan,et al. A systematic review of the association between immunogenomic markers and cancer-related fatigue , 2012, Brain, Behavior, and Immunity.
[20] P. Fransson. Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluation. , 2010, Journal of cancer research and therapeutics.
[21] P. Gascón,et al. Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer , 2010, Supportive Care in Cancer.
[22] N. Hay,et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.
[23] C. Cleeland. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. , 2007, Journal of the National Cancer Institute. Monographs.
[24] P. Chumakov,et al. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. , 2007, Cancer research.
[25] Kevin Fiscella,et al. Mechanisms of cancer-related fatigue. , 2007, The oncologist.
[26] E. Berthelet,et al. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. , 2006, The Canadian journal of urology.
[27] R. Craddock,et al. Identifying illness parameters in fatiguing syndromes using classical projection methods. , 2006, Pharmacogenomics.
[28] Lora Packel,et al. Cancer-related fatigue. , 2006, Archives of physical medicine and rehabilitation.
[29] G. Morrow,et al. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer , 2005, Cancer.
[30] E. Koonin,et al. Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.
[31] D. Cella,et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.
[32] P. Stone,et al. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. , 2001, Journal of pain and symptom management.
[33] D. Cella,et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. , 1998, Medical care.
[34] P. Reddy,et al. Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders. , 2017, Progress in molecular biology and translational science.
[35] A. Budanov,et al. Sensing the Environment Through Sestrins: Implications for Cellular Metabolism. , 2016, International review of cell and molecular biology.
[36] H. von Melchner,et al. Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury. , 2013, Antioxidants & redox signaling.